Dyne Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Dyne Therapeutics Stock Summary

Dyne Therapeutics competes with Stoke Therapeutics, Pliant Therapeutics, Cytokinetics, Revolution Medicines, and Edgewise Therapeutics. Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.. Dyne Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 108 people.

Dyne Therapeutics Key Financial Ratios

Dyne Therapeutics Key Balance Sheet Accounts

Dyne Therapeutics Key Income Statement Accounts

Dyne Therapeutics Key Cash Accounts

Dyne Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Dyne Therapeutics's current stock value. Our valuation model uses many indicators to compare Dyne Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dyne Therapeutics competition to find correlations between indicators driving Dyne Therapeutics's intrinsic value. More Info.Dyne Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Dyne Therapeutics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dyne Therapeutics' earnings, one of the primary drivers of an investment's value.

Dyne Therapeutics Systematic Risk

Today, most investors in Dyne Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Dyne Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Dyne Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Dyne Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Dyne Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Dyne Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Dyne Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Dyne Therapeutics's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.